Trade

with

Harvard Bioscience Inc
(NASDAQ: HBIO)
AdChoices
4.74
+0.02
+0.42%
After Hours :
4.74
0.00
0.00%

Open

4.69

Previous Close

4.72

Volume (Avg)

48.80k (57.46k)

Day's Range

4.68-4.75

52Wk Range

3.68-6.13

Market Cap.

153.09M

Dividend Rate ( Yield )

-

Beta

1.16

Shares Outstanding

32.30M

P/E Ratio (EPS)

107.53 (0.00)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 105.17M

    • Net Income

    • -1.83M

    • Market Cap.

    • 153.09M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 0.00

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.16

    • Forward P/E

    • -

    • Price/Sales

    • 1.45

    • Price/Book Value

    • 1.55

    • Price/Cash flow

    • 29.76

      • EBITDA

      • 5.28M

      • Return on Capital %

      • 0.00

      • Return on Equity %

      • 0.00

      • Return on Assets %

      • 0.00

      • Book Value/Share

      • 3.04

      • Shares Outstanding

      • 32.30M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 3.30

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -52.80

          • -15.59

          • Net Income

            Q/Q (last year)

          • 964.60

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 3.62

          • 12.51

          • Net Income

            5-Year Annual Average

          • -33.10

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 44.77

            • 52.83

            • Pre-Tax Margin

            • 1.02

            • 15.96

            • Net Profit Margin

            • 0.00

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 47.00

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 5.40

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 6.00

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.18

              • 0.62

              • Current Ratio

              • 3.93

              • 1.97

              • Quick Ratio

              • 2.77

              • 1.16

              • Interest Coverage

              • 1.99

              • 10.47

              • Leverage Ratio

              • 1.40

              • 2.38

              • Book Value/Share

              • 3.04

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 106.38

                • 36.10

                • P/E Ratio 5-Year High

                • 116.46

                • 279.76

                • P/E Ratio 5-Year Low

                • 55.17

                • 148.87

                • Price/Sales Ratio

                • 1.45

                • 3.35

                • Price/Book Value

                • 1.55

                • 4.19

                • Price/Cash Flow Ratio

                • 29.76

                • 17.36

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 0.00

                        (7.60)

                      • 17.93

                        (21.42)

                      • Return on Assets %

                        (5-Year Average)

                      • 0.00

                        (5.50)

                      • 7.35

                        (9.50)

                      • Return on Capital %

                        (5-Year Average)

                      • 0.59

                        (6.90)

                      • 10.24

                        (13.59)

                      • Income/Employee

                      • 8.15

                      • 25.65k

                      • Inventory Turnover

                      • 3.30

                      • 2.66

                      • Asset Turnover

                      • 0.75

                      • 0.59

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      1.54M
                      Operating Margin
                      1.46
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      29.76
                      Ownership

                      Institutional Ownership

                      61.30%

                      Top 10 Institutions

                      32.79%

                      Mutual Fund Ownership

                      28.00%

                      Float

                      94.33%

                      5% / Insider Ownership

                      17.83%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Hussman Strategic Growth Fund

                      •  

                        930,000

                      • 0.00

                      • 2.88

                      • Vanguard US Discoveries Fund

                      •  

                        872,203

                      • 0.00

                      • 2.71

                      • Vanguard VIF Small Comp Gr

                      •  

                        595,200

                      • 0.00

                      • 1.85

                      • Vanguard Total Stock Mkt Idx

                      •  

                        450,862

                      • 1.39

                      • 1.40

                      • Vanguard Extended Market Index Fund

                      •  

                        427,391

                      • 0.59

                      • 1.32

                      • Royce Micro Cap Series Fund

                      •  

                        417,679

                      • -11.79

                      • 1.29

                      • F&C Global Smaller Companies

                      •  

                        410,222

                      • 0.00

                      • 1.27

                      • Jupiter US Smaller Companies

                      •  

                        376,619

                      • 0.00

                      • 1.18

                      • Mutual of America Small Cap Value

                      •  

                        346,235

                      • 0.00

                      • 1.07

                      • Royce Capital Fund Micro-Cap Portfolio

                      •  

                        345,268

                      • 19.28

                      • 1.07

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Granahan Investment Management Inc..

                      •  

                        1,644,590

                      • -3.72%

                      • 5.09

                      • Dimensional Fund Advisors, Inc.

                      •  

                        1,520,937

                      • +0.96%

                      • 4.72

                      • BlackRock Fund Advisors

                      •  

                        1,226,565

                      • -29.52%

                      • 3.80

                      • First Light Asset Management, LLC

                      •  

                        1,014,285

                      • +5.49%

                      • 3.15

                      • Jupiter Asset Management Limited

                      •  

                        991,019

                      • +163.14%

                      • 3.07

                      • Hussman Strategic Advisors, Inc.

                      •  

                        930,000

                      • 0.00%

                      • 2.89

                      • Vanguard Group, Inc.

                      •  

                        911,084

                      • -2.02%

                      • 2.83

                      • Royce & Associates, LLC

                      •  

                        767,100

                      • 0.00%

                      • 2.38

                      • Renaissance Technologies Corp

                      •  

                        740,400

                      • +26.66%

                      • 2.30

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Instruments & Supplies

                      Type

                      Slow Growth

                      Style

                      Small Value

                      Harvard Bioscience, Inc. a Delaware corporation began in 1901. The Company is a developer, manufacturer and marketer of specialized products, like apparatus and scientific instruments, used to advance life science research at pharmac...moreeutical and biotechnology companies, universities and government laboratories. It has sales and manufacturing operations in the United States, the United Kingdom, Germany and Spain and sales facilities in France and Canada. It sells its products to researchers in over 100 countries mainly through its sales organization, catalog, website, distributors like GE Healthcare, Thermo Fisher Scientific Inc. and VWR, and via its field sales organization. Today, its broad product range is generally targeted towards two application areas; ADMET testing and molecular biology and liq...moreuid handling. ADMET Testing - The ADMET testing identifies compounds that have toxic side effects or undesirable physiological or pharmacological properties. It has products that its customers use to help their researchers conduct experiments on cells, tissues, organs and animals. The Company sells these products under the brand names including Harvard Pumps, Harvard Apparatus, Denville, Biochrom, Warner Instruments, BTX, KD Scientific, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, and CMA Microdialysis. These products are mainly scientific instruments such as spectrophotometers and plate readers that analyze light to detect and quantify molecular and cellular processes or apparatus such as gel electrophoresis units. The Company’s end-user customers are mainly research scientists at pharmaceutical and biotechnology companies, universities and government laboratories, including the U.S. National Institutes of Health, or NIH. The Company’s academic customers have included colleges and universities such as Baylor University, Cambridge University, Harvard University, Johns Hopkins University, Massachusetts Institute of Technology, Yale University and the University of Texas - MD Anderson Center. The Company’s pharmaceutical and biotechnological customers have included pharmaceutical companies and research laboratories such as Amgen, Inc., AstraZeneca plc, Genentech, Inc. and Johnson & Johnson. It competes with several companies that provide instruments for life science research including, Amaxa GmbH, Becton Dickinson, Eppendorf AG, Kent Scientific Corporation, Razel Scientific Instruments, Inc., Ugo Basile, Danaher Corporation, Bio-Rad Laboratories, Inc., MDS Analytical Technologies, PerkinElmer, Inc. and Thermo Fisher Scientific, Inc. The Company is not subject to direct governmental regulation other than the laws and regulations generally applicable to businesses in the domestic and foreign jurisdictions in which it operates.lessless

                      Key People

                      Mr. Jeffrey Duchemin

                      CEO/Director/President/Secretary

                      Earl R. Lewis

                      Director/Chairman of the Board

                      Mr. Robert E. Gagnon

                      CFO/Chief Accounting Officer/Secretary/Treasurer

                      Yong Sun

                      Vice President, Divisional

                      Yoav Sibony

                      Vice President, Divisional

                      • Harvard Bioscience Inc

                      • 84 October Hill Road

                      • Holliston, MA 01746

                      • USA.Map

                      • Phone: +1 508 893-8999

                      • Fax: +1 508 429-5732

                      • harvardbioscience.com

                      Incorporated

                      1901

                      Employees

                      368

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: